BoTox Into the Sternocleidomastoid Muscles (SCM)

Boston Medical Center (BMC)

Status and phase

Not yet enrolling

Phase 4

Conditions

Neck Muscle Issue

Treatments

Drug: prabotulinumtoxinA-xvfs

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT06903975

H-45473

Details and patient eligibility

About

Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.

Full description

The specific study objectives are to determine if:

the neck circumference is decreased at 4 weeks after botulinum toxin (prabotulinumtoxinA-xvfs) injection.
patients can appreciate a difference in their neck contour, self-confidence, and the way they perceive themselves post-injection via an aesthetics outcome and a neck perception survey.
injection of the botulinum toxin into the sternocleidomastoid muscle is safe to perform based on adverse events.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age eligible individual seeking a more feminine neck appearance

Exclusion criteria

Prior neuromodulator injections in the sternocleidomastoid muscles (SCM) within the past year
Current anticoagulant use
Body mass index (BMI) >30
Anticipation of significant weight gain or loss during the study period (e.g. patients taking or planning to take within the study period a semaglutide medication.)
Prior allergy to botulinum toxin A
Currently pregnant or breastfeeding